Fipamezole in Neurogenic Orthostatic Hypotension

NCT00758849 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Symptomatic Neurogenic Orthostatic Hypotension (NOH)
Parkinson's Disease
Multiple System Atrophy

Interventions

DRUG: Placebo
DRUG: Fipamezole

Sponsor

Juvantia Pharma Ltd

Collaborators

[object Object]